Ver mas grande
ELISA Kit for N-Terminal Pro-Brain Natriuretic Peptide (NT-ProBNP)
CC-SEA485Hu
Producto nuevo
48T, 96T, 96T×5, 96T×10, 96T×100
Comprando este producto generará 4 Biopuntos. Su cesta contiene un total 4 Biopuntos puede ser convertido en un Biobonos Descuento 16.00EUR.
Hoja técnica
| Size | 96T |
| Storage Conditions | -20°C |
| Shipping Conditions | Entre 4°C y 8°C |
| Applications | Enzyme-linked immunosorbent assay for Antigen Detection. |
| Detection Range | 39-2500pg/mL |
| Sensitivity | The minimum detectable dose of this kit is typically less than 15pg/mL |
| Research Area | Endocrinology |
| Organism species | Homo sapiens (Human) |
| Alternative Names | NT-Pro-BNP |
| Item Name | N-Terminal Pro-Brain Natriuretic Peptide |
| Assay Length | 3h |
| Method | Double-antibody Sandwich |
| Sample Type | serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids |
| Formato | 48T, <i>96T</i>, 96T×5, 96T×10, 96T×100 |
| Test Principle | The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to N-Terminal Pro-Brain Natriuretic Peptide (NT-ProBNP). Standards or samples are then added to |
| Assay procedure summary | 1. Prepare all reagents, samples and standards |
| UniProt ID | P16860 |
Más información
CITATIONS
The role of serum n-terminal pro-brain natriuretic peptide in transient tachypnea of the newborn;Paradoxical low-flow, low-gradient aortic stenosis despite preserved left ventricular ejection fraction: new insights from weights of operatively excised aortic valves;A Randomized Controlled Trial to Study the Effect of Yoga Therapy on Cardiac Function and N Terminal Pro BNP in Heart Failure;Growth-differentiation factor 15 and osteoprotegerin in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the IABP-SHOCK II-trial.;Biomarkers and Echocardiographic Predictors of Myocardial Dysfunction in Patients with Hypertension;The Multi-Biomarker Approach for Heart Failure in Patients with Hypertension;Effect of Treatment on Body Fluid in Patients with Unilateral Aldosterone Producing Adenoma: Adrenalectomy versus Spironolactone;NT-proBNP in Children With Left to Right Shunt and Dilated Cardiomyopathy;Human myoblast transplantation in mice infarcted heart alters the expression profile of cardiac genes associated with left ventricle remodeling;Cardiovascular changes in patients with non-severe Plasmodium vivax malaria;Soluble Glycoprotein 130 and Heat Shock Protein 27 as Novel Candidate Biomarkers of Chronic Heart Failure with Preserved Ejection Fraction;Differences in biochemical and genetic biomarkers in patients with heart failure of various etiologies.;Expression of pericardial fluid T-cells and related inflammatory cytokines in patients with chronic heart failure.;Study of Vitamin D Status in Patients with Dilated Cardiomyopathy at a Teaching Hospital in North India.;5-methoxytryptophan is a potential marker for post-myocardial infarction heart failure - apreliminary approach to clinical utility.;Beneficial Effects of Ozone Therapy on Oxidative Stress, Cardiac Functions and Clinical Findings in Patients with Heart Failure Reduced Ejection Fraction;Serial heart rhythm complexity changes in patients with anterior wall ST segment elevation myocardial infarction.;The predictive capabilities of a novel cardiovascular magnetic resonance derived marker of cardiopulmonary reserve on established prognostic surrogate markers in patients with pulmonary vascular disease: results of a longitudinal pilot study;Evaluation of N-Terminal Pro Brain Natriuretic Peptide as a biomarker for clinical severity of heart failure in pediatric population;Role of NT-proANP and NT-proBNP in patients with atrial fibrillation: Association with atrial fibrillation progression phenotypes;MicroRNAs in Peripheral Mononuclear Cells as Potential Biomarkers in Hypertensive Patients With Heart Failure With Preserved Ejection Fraction;Regulation of circulating chromogranin B levels in heart failure;Effect of 6-min Walk Test on pro-BNP Levels in Patients with Pulmonary Arterial Hypertension;Dynamic monitoring the level of NT-proBNP in assessing the value of cardiac function and prognosis in patients with systemic infection;Decreasing cardiac iron overload with Amlodipine and Spirulina in children with β-thalassemia;Acute Responses of Novel Cardiac Biomarkers to a 24-h Ultra-Marathon;Biological markers for the effects of yoga as a complementary and alternative medicine;Arterial Stiffness and Indices of Left Ventricular Diastolic Dysfunction in Patients with Embolic Stroke of Undetermined Etiology;Hormonal Response to Incremental and Continuous Exercise in Cyclists with Left Ventricle Hypertrophy;Evaluating the Relationship of GDF-15 with Clinical Characteristics, Cardinal Features, and Survival in Multiple Myeloma;Left Ventricular Diastolic Dysfunction as Predictor of Unfavorable Prognosis After ESUS;Hemodynamic Responses in Lower Limb Lymphedema Patients Undergoing Physical Therapy;Risk Stratification of Pulmonary Thromboembolism using Brain Natriuretic Peptide and Troponin I; a Brief Report;The Key Role of Hepcidin-25 in Anemia in Multiple Myeloma Patients with Renal Impairment;